NEW YORK, April 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025.So what: If you purchased Merck securities during the Class Period you ma ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Monolithic Power Systems, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Monolithic Power Systems common stock between February 8, 2024, and November 8, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the law firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is April 7, 2025, with the lead plaintiff acting on behalf of other class members [3]. Group 2: Background of the Case - The lawsuit alleges that Monolithic Power Systems made materially false and misleading statements regarding its voltage regulator modules and power management integrated circuits, which suffered from significant performance and air quality issues [5]. - These defects reportedly affected the performance of products offered by Nvidia that utilized Monolithic Power Systems' components, leading to a damaged relationship between the two companies [5]. - The lawsuit claims that Monolithic Power Systems failed to adequately address known issues, exposing the company to undisclosed risks of significant business, financial, and reputational harm [5].

Core Viewpoint - Rosen Law Firm is reminding purchasers of ICON plc ordinary shares during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors [1][2]. Group 1: Class Action Details - The Class Period for the lawsuit is from July 27, 2023, to October 23, 2024, inclusive [1]. - Investors who purchased shares during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 11, 2025 [2]. Group 2: Reasons for Selecting Rosen Law Firm - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [3]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [3]. Group 3: Allegations Against ICON plc - The lawsuit alleges that ICON made false and misleading statements regarding its business performance and client demand during the Class Period [4]. - Specific claims include that ICON suffered a material loss of business due to customer cost reductions and funding limitations, and that its service offerings were insufficient to mitigate market downturn impacts [4]. - The lawsuit also states that ICON's reported business metrics misrepresented actual client demand, leading to a significant discrepancy between reported guidance and actual performance [4].

Core Viewpoint - A class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. for alleged misleading statements regarding the approval process of its Iomab-B Biologics License Application during the Class Period from October 31, 2022, to August 2, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Actinium made false statements and failed to disclose critical information about the likelihood of FDA approval for its Iomab-B BLA [5]. - Specific allegations include that data from the Sierra Trial was unlikely to meet FDA guidelines, and additional analyses provided to the FDA were also unlikely to satisfy approval requirements [5]. - As a result of these misleading statements, investors reportedly suffered damages when the true information became public [5]. Group 2: Participation Information - Investors who purchased Actinium securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors and has been ranked highly for its performance in securities class action settlements [4].

Core Points - Rosen Law Firm is reminding purchasers of FMC Corporation securities from November 16, 2023, to February 4, 2025, about the April 14, 2025, lead plaintiff deadline [1] - Investors who purchased FMC securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Class Action Details - A class action lawsuit has been filed against FMC Corporation, alleging that the company made false and misleading statements regarding its channel management initiatives and pricing strategies [4] - The lawsuit claims that FMC inflated inventory in various regions, including Latin America, Asia, Canada, and Eastern Europe, leading to materially misleading statements about its business and operations [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [3] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its leadership in securities class action settlements [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Rocket Lab USA, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][3]. Group 1: Class Action Details - Investors who bought Rocket Lab securities between November 12, 2024, and February 25, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 28, 2025 [3][5]. - The lawsuit alleges that Rocket Lab made false or misleading statements regarding its operations and business prospects, including significant delays in barge landing tests and issues with the launch pad preparation [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Elastic N.V. securities between May 31, 2024, and August 29, 2024, of the April 14, 2025, deadline to become lead plaintiffs in a class action lawsuit due to alleged misleading statements by the company [1][4]. Group 1: Class Action Details - Investors who bought Elastic securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by April 14, 2025, to serve as lead plaintiff [2]. - The lawsuit claims that Elastic made false and misleading statements regarding its sales operations and revenue guidance, which led to investor damages when the truth was revealed [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3].

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Target Corporation (NYSE: TGT) between August 26, 2022 and November 19, 2024, both dates inclusive (the "Class Period"), of the important April 1, 2025 lead plaintiff deadline. SO WHAT: If you purchased Target common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased TFI International Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on May 13, 2025 [1]. Group 1: Class Action Details - Investors who purchased TFI International securities between April 26, 2024, and February 19, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6]. - The lawsuit claims that TFI International made false or misleading statements regarding its business operations, leading to investor damages when the truth was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Fluence Energy, Inc. common stock about the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during a specified class period [1][5]. Group 1: Class Action Details - The class period for the lawsuit is from November 29, 2023, to February 10, 2025, and the lead plaintiff deadline is May 12, 2025 [1]. - Investors who purchased Fluence common stock during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6]. Group 2: Allegations Against Fluence - The lawsuit alleges that Fluence made false and misleading statements regarding its business relationships and financial performance [5]. - Specific claims include that Fluence's relationship with Siemens AG and The AES Corporation was expected to decline, and that Siemens Energy accused Fluence of engineering failures and fraud [5]. - The lawsuit asserts that Fluence's reported margins and revenue growth were inflated, and that the company lacked a reasonable basis for its positive statements about its battery energy storage business [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a leading figure in the plaintiffs' bar [4].